Kevin Mclaughlin - Oct 10, 2022 Form 3 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
Director
Signature
Jeffrey W. Schulz, Attorney-in-Fact
Stock symbol
DBTX
Transactions as of
Oct 10, 2022
Transactions value $
$0
Form type
3
Date filed
10/12/2022, 08:13 AM
Previous filing
Apr 29, 2022
Next filing
Apr 28, 2023

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney